Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Talk with a licensed healthcare provider about risks and whether its appropriate for you
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Prescriptions are up to a medical providers discretion
Understanding constipation management , bloating solutions , dizziness , and fatigue on GLP-1 compounds gives you practical tools to push through the adjustment period without abandoning the protocol
Increased heart rate: Some people report a rapid or pounding heartbeat, even without an obvious trigger
Which makes the entire thing culturally interesting almost immediately
US$ 20.43
US$ 21.34
US$ 29.53
US$ 23.66
